D. Moller

Causes of hypereosinophilia in 100 consecutive patients.

H. Bruyèrè, M. Hudoba, M. Carruthers, 2020, European journal of haematology.

Pegylated interferon alpha 2a is an effective and well‐tolerated treatment option for lymphocyte‐variant hypereosinophilic syndrome

Erica A. Peterson, J. Dutz, C. Choi, 2019, British journal of haematology.

Distress in Caregivers Accompanying Patients to an Emergency Department: A Scoping Review.

A. Mutsaers, D. Moller, T. Ringer, 2017, The Journal of emergency medicine.